Hagen Brett R (CIK 1681782) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-23). Recent activity: Sell KLRS (1,915 shares), Sell KLRS (907 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-23 | Kalaris Therapeutics, Inc. (KLRS) | Chief Accounting Officer | Sell | 1,915 | $12,869 |
| 2025-03-27 | Kalaris Therapeutics, Inc. (KLRS) | Chief Accounting Officer | Sell | 907 | $8,136 |
Source: SEC Form 4 filings · as of 2026-03-23